What Can You Expect?
This event presents practical evidence-based education on cannabinoid therapeutics. Participants will benefit from presentations by Canadian and internationally renowned experts in a two-day hybrid event featuring updates from key researchers and stakeholders.
We’ve worked to make this conference the most comprehensive to date. Below is some of what to expect when you attend Cannabinoids in Clinical Practice 2022.
- CCIC is proud to announce that we have partnered with the Toronto Cannabis and Cannabinoid Research Consortium (TC3) to bring even greater interactive opportunities and translational learning than previous conferences, including a new poster session for in-person attendees and panel discussions addressing challenges in cannabinoid therapeutics in real world situations.
- Canadian physicians and healthcare professional attendees will be updated on the evolving regulatory system and educated on the current state of knowledge regarding the health effects of cannabis and familiarized with emerging research to provide safe and effective use of cannabinoids in clinical practice.
- This event will educate health care professionals to foster accurate and evidence-based conversations with their patients on the health impacts of cannabis and will update researchers in the field on what the latest science says.
- Proof of vaccination verification is required upon check-in and mandatory masking rules will apply.
The 8th Annual Cannabinoids in Clinical Practice Conference is proudly co-hosted with the Toronto Cannabis and Cannabinoid Research Consortium (TC3)!